Basic Clotrimazole Information

• INN (International Nonproprietary Name): Clotrimazole.
• Brand Names Available In Canada (English): Canesten, Clotrimaderm, Desenex, Myclo‑Derm, Neo‑Zol, typically sold as creams, lotions, dusting powders and vaginal tablets.
• ATC Code: D01AC01 (topical) and G01AF02 (vaginal use), classification Antifungal, Imidazole derivative.
• Forms & Dosages: Cream 1% and 2%; Tablet/Vaginal 100 mg and 500 mg; Solution 1%; Lotion 1%; Powder 1%.
• Manufacturers In Canada (English): Major global and generic suppliers listed in product information include Bayer (Canesten), Schering‑Plough (Gyne‑Lotrimin), GSK, Ranbaxy, Teva, Glenmark, Fougera, Taro, Merck, Paddock, Actavis and Roxane.
• Registration Status In Canada (English): Widely available OTC and by prescription in North America and registered with national authorities as indicated in international product listings.
• OTC / Rx Classification: In most countries 1% topical creams, solutions and dusting powders are OTC, while some vaginal tablets or higher‑strength/combination products may be Rx.

Latest Research Highlights (Canadian & International, 2022–2025)

Worried that resistance or new evidence has changed how clotrimazole is used?

Recent Canadian and international studies from 2022 to 2025 reinforce clotrimazole's continued efficacy for superficial fungal infections and vulvovaginal candidiasis.

Systematic reviews and randomized trials still show topical clotrimazole 1%–2% is effective for tinea corporis and is favoured as a first‑line topical for many cases of vulvovaginal candidiasis when compared with other azoles.

Single‑dose 500 mg and multi‑day 100 mg vaginal regimens show comparable cure rates in clinical practice and published trials.

Emerging evidence highlights local resistance patterns among non‑albicans Candida species and occasional reduced dermatophyte susceptibility, but primary resistance remains uncommon in most settings.

"International Nonproprietary Name (INN) Clotrimazole" and dosage forms "Cream 1%, 2%; Tablet/Vaginal 100 mg, 500 mg" are commonly used in trials and practice.

• Study Limitations: Many trials are topical versus topical comparators, short follow‑up, and variable species confirmation.
• Clinical Takeaways: Treatment failure often reflects reinfection, incomplete adherence, or misdiagnosis rather than universal resistance.

Clinical Effectiveness In Canada (Health Canada Guidance & DINs)

Do Canadian guidelines and formularies support clotrimazole for routine fungal care?

Health Canada recognises multiple topical and vaginal clotrimazole products that carry Drug Identification Numbers (DINs) when marketed in Canada.

Canadian dermatology and gynaecology monographs support clotrimazole 1% cream for superficial dermatophyte and yeast infections and support 100 mg and 500 mg vaginal tablets for vulvovaginal candidiasis.

Comparative trials show short‑term cure rates similar to miconazole for uncomplicated thrush, and topical imidazoles remain first‑line for many non‑complicated cases.

Regulatory Status & Approvals — United States/Canada: Widely available OTC and by prescription.

DIN Checklist: include Product, Strength, Form, DIN and Formulary Status on prescriptions and pharmacist records to help with reimbursement and benefits adjudication.

• Provincial Coverage Notes: Some public plans may cover vaginal tablets under specific criteria, so verify ODB, BC PharmaCare or RAMQ requirements.
• Steps To Verify DIN And Reimbursement: check the product label for DIN, consult provincial formulary online, and document the DIN on the claim.

Indications And Expanded Uses (Approved Vs Off‑Label In Canadian Practice)

Not sure when to use a cream versus a vaginal tablet?

Approved indications in Canada follow international labelling and include tinea pedis, corporis and cruris, candidal intertrigo, and vulvovaginal candidiasis for vaginal tablets and creams.

Common approved dosing is tinea — apply 1% cream two to three times daily for two to four weeks, and vulvovaginal candidiasis — 100 mg vaginal tablet nightly for six nights or a single 500 mg tablet.

Off‑label topical uses reported in practice include adjunctive therapy for pityriasis versicolour and some contact yeast infections, while oropharyngeal lozenges exist internationally but are rarely available in Canada.

• Approved: topical 1% for tinea and 100 mg/500 mg vaginal tablets for thrush.
• Off‑Label: pityriasis versicolour adjunct therapy and some minor cutaneous yeast infections where topical application is practical.

Practical Note: topical creams are often the easiest option in remote or Indigenous communities where access to ovules is limited, and bilingual labelling helps adherence in francophone regions.

Composition And Brand Landscape In Canada

Which brands should patients recognise on the shelf or online?

In Canada notable brand names include Canesten, Clotrimaderm, Desenex, Myclo‑Derm and Neo‑Zol, with generics supplied by major manufacturers keeping prices competitive.

The active ingredient across brands is clotrimazole, typically 1% or 2% in topical forms and 100 mg/500 mg for vaginal tablets.

Brand comparison at a glance: Canesten and Clotrimaderm commonly appear in retail pharmacies while generics from Teva, Actavis and others are widely stocked by chains.

• Formulation Pros And Cons: creams for easy local application, powders for moisture control in feet, and ovules for single‑site vaginal dosing.
• Pricing Patterns: brand premiums are common for Canesten while generics offer lower cost alternatives for price‑sensitive patients.

Chain Availability: Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs typically stock both brands and generics and e‑pharmacies list clotrimazole cream, powder and vaginal tablets for home delivery.

Contraindications And Special Precautions (Canadian Focus)

What are the must‑know safety warnings before using clotrimazole?

Absolute contraindication is known hypersensitivity to clotrimazole or other imidazoles, and the product must never be used in the eyes.

Caution is advised on broken or inflamed skin because increased absorption can occur, and Health Canada advises monitoring for allergic contact dermatitis with topical imidazoles.

Pregnancy and lactation guidance: topical and vaginal use is generally considered safe but consult the prescriber for any specific concerns.

• Absolute Contraindications — Known hypersensitivity to clotrimazole or imidazoles; ophthalmic use is contraindicated.
• Relative Contraindications — broken/inflamed skin, long‑term repeated use requiring monitoring for sensitization.

High‑Risk Groups: elderly patients with fragile skin, immunocompromised individuals and patients with diabetes or skin barrier problems may need closer follow‑up and culturally appropriate counselling in Indigenous communities.

Dosage Guidelines (Standard Canadian Regimens & Adjustments)

How should patients dose clotrimazole for common infections?

Tinea: apply 1% cream to the affected area two to three times daily for two to four weeks, continuing at least two weeks after symptom resolution.

Vulvovaginal Candidiasis: use a 100 mg vaginal tablet nightly for six nights, or choose the single 500 mg tablet for one‑day therapy where appropriate.

Oropharyngeal lozenges are 10 mg five times daily for 14 days in markets where they are available, but these lozenges are not common in Canada.

Adjustments: no routine dose change needed for elderly or renal impairment with topical use, and topical/vaginal forms require no adjustment for liver disease, while oral azoles need caution in severe hepatic dysfunction.

Interactions Overview (Drug, Food, Lifestyle In Canadian Context)

Will clotrimazole interfere with medications or lifestyle habits?

Topical and vaginal clotrimazole have minimal systemic absorption and clinically significant drug interactions are rare for these formulations.

Oral azoles can interact with CYP450 substrates, but oral clotrimazole is seldom used in Canada so systemic interaction risk from clotrimazole products sold OTC is low.

• Topical/Vaginal: no routine adjustment for liver or kidney impairment and negligible food or alcohol interactions.
• Systemic Considerations: if a patient is exposed to systemic azoles concurrently, monitor warfarin or certain statins as per usual systemic azole guidance.

Pharmacy Practice Tip: pharmacists should flag combination products that include corticosteroids or antibiotics since those combinations change the safety profile compared with single‑ingredient clotrimazole products.

Cultural Perceptions And Patient Habits (Canada‑Specific Insights)

Do Canadians trust clotrimazole and how do they choose to buy it?

Patient feedback on Canadian forums and pharmacy conversations suggests clotrimazole brands like Canesten are seen as familiar, affordable and effective.

Stigma around intimate infections makes many people prefer pharmacist counselling, anonymous e‑pharmacy orders or discreet packaging when buying vaginal tablets or creams.

Rural and northern patients report occasional stock variability and longer waits, and bilingual labelling with pharmacist counselling improves adherence in Québec and other francophone areas.

• Urban Vs Rural Access: urban centres typically have immediate retail access while remote communities often rely on mail orders or local nursing stations.
• Practical Counselling: use plain language leaflets, visual dosing cues and private consultation rooms to reduce stigma and improve adherence.

Availability And Pricing Patterns (Retail & Cross‑Border)

Where can patients buy clotrimazole and how much should they expect to pay?

Clotrimazole topical and vaginal products are widely available across Canadian retailers such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, and from licensed Canadian e‑pharmacies.

Prices vary by brand and form, with Canesten often priced higher than generics stocked by Teva, Actavis and other suppliers.

Most countries list 1% topical creams, solutions and dusting powders as OTC, and Canadian pharmacists commonly recommend OTC 1% products for uncomplicated infections.

• Purchasing Options: in‑store retail purchase, online pharmacy order with mail delivery, or mail‑order refill programs for remote patients.
• Cross‑Border Notes: US products use NDCs rather than DINs and import rules limit use of non‑DIN products, so pharmacists should advise caution when patients consider cross‑border purchases.

Purchase Context: in our online pharmacy, clotrimazole is available without a prescription, with discreet delivery to Canada in 5‑14 days.

Comparable Medicines And Patient Preferences (Alternatives In Canada)

When might a different antifungal be a better choice?

Alternatives available in Canada include miconazole, terbinafine, econazole and tioconazole, and choice depends on the likely pathogen, patient preference and cost.

Terbinafine is often favoured for dermatophyte infections because a shorter treatment course can be effective, while imidazoles like miconazole and clotrimazole are commonly used for yeast infections.

Patient Preference Factors: some patients prefer a single‑dose 500 mg ovule for adherence while others choose topical creams for privacy or local irritation control, and pharmacists should weigh pregnancy safety and provincial coverage when recommending alternatives.

FAQ — Common Canadian Patient Questions

Q: Can I buy clotrimazole over the counter in Canada?

A: Yes — most 1% topical creams and powders are OTC and many vaginal tablets are available OTC but check the packaging and DIN for specific products.

Q: Is clotrimazole safe in pregnancy or breastfeeding?

A: Topical and vaginal clotrimazole are generally considered safe in pregnancy and lactation, but discuss any use with your healthcare provider.

Q: How long before symptoms improve?

A: Symptomatic relief can begin within days, but complete treatment for skin infections should continue for two to four weeks and follow product directions for vaginal regimens of one to six days.

Q: What if symptoms recur?

A: Return to a pharmacist or clinician for reassessment, consider species testing for non‑albicans Candida or dermatophyte persistence, and review adherence and reinfection sources.

Guidelines For Proper Use (Pharmacist & Provincial Tips)

How should pharmacists assess and counsel patients buying clotrimazole?

Confirm a clinical diagnosis and differentiate tinea from candidiasis before recommending a topical or vaginal formulation.

Advise patients to complete the full course of topical therapy, avoid sexual activity during acute vaginal infection or to use protection, and to follow product labelling carefully.

Document the DIN on prescriptions and pharmacist records and check provincial formularies for substitution and coverage rules before suggesting a covered option.

• Dispensing Steps: assess symptoms, select formulation, provide dosing and duration, explain common side effects and arrange follow‑up if symptoms persist.
• Provincial Resources: direct patients to ODB (Ontario), BC PharmaCare, and RAMQ for formulary and coverage questions and report adverse reactions via MedEffect Canada.

Operational Notes: offer bilingual counselling in Québec, use private consultation rooms to reduce stigma, and consider mail‑order or local nursing coordination for Indigenous and remote communities.

Delivery Across Canada (English)